Aug 11, 2023 07:45AM
Aug 9, 2023 07:32AM
Aug 9, 2023 07:30AM
May 15, 2023 07:45AM
May 12, 2023 07:00AM
May 12, 2023 07:00AM
Mar 30, 2023 07:03AM Decibel Therapeutics (DBTX) Receives European Orphan Drug Designation for Lead Gene Therapy Candidate DB-OTO
Mar 30, 2023 07:00AM
Mar 30, 2023 07:00AM
Mar 14, 2023 04:05PM
Mar 14, 2023 04:05PM
Jan 24, 2023 07:02AM
Jan 24, 2023 07:00AM
Jan 24, 2023 07:00AM Decibel Therapeutics Announces Approval of Clinical Trial Application by the U.K. Medicines and Healthcare Products Regulatory Agency for Lead Gene Therapy Candidate DB-OTO
Nov 9, 2022 04:44PM
Nov 9, 2022 04:44PM
Nov 2, 2022 07:00AM
Nov 2, 2022 07:00AM
Oct 17, 2022 07:00AM
Oct 17, 2022 07:00AM
Oct 17, 2022 07:00AM Decibel Therapeutics Receives FDA Clearance of IND Application for DB-OTO, a Gene Therapy Product Candidate Designed to Provide Hearing to Individuals with Otoferlin-Related Hearing Loss
Sep 20, 2022 07:03AM
Sep 20, 2022 07:00AM
Sep 20, 2022 07:00AM
Aug 10, 2022 04:30PM
Aug 10, 2022 04:30PM
May 12, 2022 07:30AM
May 12, 2022 07:30AM Decibel Therapeutics Reports First Quarter 2022 Financial Results and Corporate Update
Mar 18, 2022 07:01AM
Mar 18, 2022 07:00AM
Mar 18, 2022 07:00AM
Nov 15, 2021 06:00AM
Nov 10, 2021 07:30AM
Nov 10, 2021 07:30AM
Sep 9, 2021 07:31AM Decibel Therapeutics (DBTX) Receives Orphan Drug and Rare Pediatric Disease Designations for DB-OTO for the Treatment of Otoferlin-Related Congenital Hearing Loss
Sep 9, 2021 07:30AM
Sep 9, 2021 07:30AM
Aug 10, 2021 07:30AM
Aug 10, 2021 07:30AM
Jun 2, 2021 08:33AM
Jun 2, 2021 08:30AM
Jun 2, 2021 08:30AM Decibel Therapeutics Appoints Dr. William H. Carson as Chairman of the Board of Directors
May 24, 2021 04:15PM
May 24, 2021 04:15PM
May 13, 2021 05:05PM
May 13, 2021 05:05PM
Mar 29, 2021 04:05PM
Mar 29, 2021 04:05PM

322,084 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All